(2023) 152(6):e2023062922
As such, the Company believes there may be a significant market opportunity for a medical food product that distinguishes itself from dietary supplements by virtue of its extensive clinical data package in sarcopenia associated with other muscle loss-related medical conditions and -stringent cGMP manufacturing requirements. Mr
Patients should follow the instructions provided by their clinician and dispensing pharmacy for preparation, dosing, and injection technique
Other risk factors include advancing age (more common in people over 60), chronic alcohol consumption, and certain genetic conditions affecting B12 metabolism
Consistent with our current policy, for CY 2026, we proposed to retain services within New Technology APC groups until we obtain sufficient claims data to justify reassignment of the service to an appropriate clinical APC
6), corresponding to alpha helices